Back to the Top
The following message was posted to: PharmPK
Dear colleagues,
Thank you for the technical advice your are sharing with us thru
pharmPK as
these provide enlightenment on some BA/BE issues.
I understand that BE for locally acting topical drug products is waived;
however for those with systemic action i.e. topical corticosteroids,
how is
the BE done? Or has anyone conducted a BE on this type of products?
I
would highly appreciate insights on this topic.
Sincerely,
Joy
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)